Literature DB >> 27527787

MiR-22 promotes porcine reproductive and respiratory syndrome virus replication by targeting the host factor HO-1.

Shuqi Xiao1, Taofeng Du2, Xue Wang3, Huaibao Ni4, Yunhuan Yan5, Na Li6, Chong Zhang7, Angke Zhang8, Jiming Gao9, Hongliang Liu10, Fengxing Pu11, Gaiping Zhang12, En-Min Zhou13.   

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most economically important viruses affecting the swine industry worldwide. MicroRNAs (miRNAs) play vital roles in virus-host interactions by regulating the expression of viral or host gene at posttranscriptional level. Our previous research showed that PRRSV infection down-regulates the expression of heme oxygenase-1 (HO-1), a pivotal cytoprotective enzyme, and overexpression of HO-1 inhibits PRRSV replication. In this study, we demonstrate that host miRNA miR-22 can downregulate HO-1 expression by directly targeting its 3' untranslated region. Suppression of HO-1 expression by miR-22 facilitates PRRSV replication. This work suggests that PRRSV may utilize cellular miRNA to modify antiviral host factor expression, enabling viral replication, which not only provides new insights into virus-host interactions during PRRSV infection, but also suggests potential therapies for PRRSV infection.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HO-1; PRRSV; Post-transcriptional regulation; Virus-cell interaction; miRNA

Mesh:

Substances:

Year:  2016        PMID: 27527787     DOI: 10.1016/j.vetmic.2016.07.026

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  Host Cells Actively Resist Porcine Reproductive and Respiratory Syndrome Virus Infection via the IRF8-MicroRNA-10a-SRP14 Regulatory Pathway.

Authors:  Zifang Zheng; Xiali Fu; Xue Ling; Huanhuan Sun; Yang Li; Zhiqian Ma; Bingjie Wei; Haixue Zheng; Shuqi Xiao
Journal:  J Virol       Date:  2022-03-16       Impact factor: 6.549

2.  The Antimalaria Drug Artesunate Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication by Activating AMPK and Nrf2/HO-1 Signaling Pathways.

Authors:  Feixiang Long; Mingxin Zhang; Xia Yang; Xiaohuan Liang; Lizhan Su; Tongqing An; Guihong Zhang; Zhenling Zeng; Yahong Liu; Weisan Chen; Jianxin Chen
Journal:  J Virol       Date:  2021-11-17       Impact factor: 6.549

3.  MicroRNA expression profiling in alveolar macrophages of indigenous Chinese Tongcheng pigs infected with PRRSV in vivo.

Authors:  Xiang Zhou; Jennifer J Michal; Zhihua Jiang; Bang Liu
Journal:  J Appl Genet       Date:  2017-10-02       Impact factor: 3.240

4.  Genome-wide integrated analysis of miRNA and mRNA expression profiles to identify differentially expressed miR-22-5p and miR-27b-5p in response to classical swine fever vaccine virus.

Authors:  Lalrengpuii Sailo; Amit Kumar; Vaishali Sah; Rajni Chaudhary; Vikramaditya Upmanyu; A K Tiwari; Ajay Kumar; Aruna Pandey; Shikha Saxena; Akansha Singh; Sajad Ahmad Wani; Ravi Kumar Gandham; Anil Rai; B P Mishra; R K Singh
Journal:  Funct Integr Genomics       Date:  2019-05-28       Impact factor: 3.674

5.  Inducible miR-150 Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication by Targeting Viral Genome and Suppressor of Cytokine Signaling 1.

Authors:  Sihan Li; Xuan Zhang; Yao Yao; Yingqi Zhu; Xiaojie Zheng; Fang Liu; Wenhai Feng
Journal:  Viruses       Date:  2022-07-07       Impact factor: 5.818

6.  The tissue specific regulation of miR22 expression in the lung and brain by ribosomal protein L29.

Authors:  Mohammad Ishaque Ali; Linrui Li; Lexing Li; Lun Yao; Jie Liu; Wei Gu; Shuguang Huang; Bingyu Wang; Guoquan Liu
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

Review 7.  miRNA Regulatory Functions in Farm Animal Diseases, and Biomarker Potentials for Effective Therapies.

Authors:  Duy N Do; Pier-Luc Dudemaine; Manisha Mathur; Prashanth Suravajhala; Xin Zhao; Eveline M Ibeagha-Awemu
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.